Samia Aleem

Assistant Professor of Pediatrics

Pediatrics, Neonatology

samia.aleem@duke.edu

2424 Erwin Road, Hock Plaza I, Durham, NC 27705

AT A GLANCE

Credentials
1. Education
2. Training & Certifications

Academic Experience

Expertise
1. Keywords

Research
1. Research Interests
2. Selected Grants

Publications
1. Selected Publications

Artistic Works / Events

Teaching

Advising & Mentoring

Recognition

Professional Activities

Manage Profile

Embed Profile Data

Research Interests

My research focus includes large epidemiological database analyses to improve the health and outcomes of premature and critically ill infants. In particular, I am interested in neonatal infections, chronic lung disease, and improving the care and outcomes of infants with congenital diaphragmatic hernias.

Selected Grants

NICHD Pediatric and Maternal Resource Center: Bridging Pharmacology and the Real World

ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024 - 2028

HEAL Clinical Coordinating Resource Center for the Pain Management Effectiveness Research Network

ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2027

BPCA Innovative Trial Designs and Assay Developments in Pediatric Therapeutics

ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2026

A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD)

Clinical TrialPrincipal Investigator · Awarded by Airway Therapeutics · 2021 - 2025

A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD)

Clinical TrialPrincipal Investigator · Awarded by Airway Therapeutics · 2021 - 2025

BPCA Data Closeout, Results Dissemination, And Stakeholder Engagement (Version 2.0)

ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2025

A Phase 2, Two-Stage, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS0071 in Newborns with Moderate or Severe Hypoxic-Ischemic Encepha

Clinical TrialPrincipal Investigator · Awarded by ReAlta Life Sciences, Inc. · 2023 - 2025

Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)

ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2025

A MULTICENTER, OPEN-LABEL, RANDOMIZED, ACTIVE COMPARATOR STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF LACOSAMIDE IN NEONATES WITH REPEATED ELECTROENCEPHALOGRAPHIC NEONATAL SEIZURES

Clinical TrialPrincipal Investigator · Awarded by UCB Biopharma SPRL · 2020 - 2024